Compound Summary
Compound Information
CEPHALOTHIN SODIUM
Compound Name: | CEPHALOTHIN SODIUM |
Compound CID: | 23675321 |
Synonyms: | CEPHALOTHIN SODIUM 58-71-9 cefalotin sodium Sodium cephalothin Cephalothin sodium salt More... |
Iupac Name: | sodium;(6R,7R)-3-(acetyloxymethyl)-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
InChI: | InChI=1S/C16H16N2O6S2.Na/c1-8(19)24-6-9-7-26-15-12(14(21)18(15)13(9)16(22)23)17-11(20)5-10-3-2-4-25-10;/h2-4,12,15H,5-7H2,1H3,(H,17,20)(H,22,23);/q;+1/p-1/t12-,15-;/m1./s1 |
InChIKey: | VUFGUVLLDPOSBC-XRZFDKQNSA-M |
Canonical Smiles: | CC(=O)OCC1=C(N2C(C(C2=O)NC(=O)CC3=CC=CS3)SC1)C(=O)[O-].[Na+] |
Isomeric Smiles: | CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)CC3=CC=CS3)SC1)C(=O)[O-].[Na+] |
Molecular Weight: | 418.4 |
Molecular Formula: | C16H15N2NaO6S2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
CEPHALOTHIN SODIUM
Molecular Weight: | 418.4 |
Molecular Formula: | C16H15N2NaO6S2 |
Hydrogen Bond Donor Count: | 1 |
Hydrogen Bond Acceptor Count: | 8 |
Rotatable Bond Count: | 7 |
Heavy Atom Count: | 27 |
Complexity: | 686 |
Synonyms
CEPHALOTHIN SODIUM
| CEPHALOTHIN SODIUM | CEPHALOTHIN SODIUM |
|---|---|
CEPHALOTHIN SODIUM |
58-71-9 |
cefalotin sodium |
Sodium cephalothin |
Cephalothin sodium salt |
Sodium cefalotin |
Sodium cephalotin |
Keflin |
Cefalotina sodica |
Seffin |
Cefalotin sodium salt |
Synclotin |
Cephalothin (sodium) |
UNII-C22G6EYP8B |
Sodium (6R,7R)-3-(acetoxymethyl)-8-oxo-7-(2-(thiophen-2-yl)acetamido)-5-thia-1-azabicyclo4.2.0oct-2-ene-2-carboxylate |
Cefalothin sodium |
C22G6EYP8B |
7-(Thiophene-2-acetamido)cephalosporanic acid sodium salt |
CHEBI:3542 |
MFCD00072025 |
Cefalothine |
Toricelocin |
Ceporacin |
Cepovenin |
Lospoven |
Microtin |
Cet Injektionsfl |
Tokiosarl Ampullen |
Keflin In Plastic Container |
Cephalotin sodium salt |
Lovvalline Injektionsfl |
MLS000069577 |
Lilly 38253 |
Keflin N Injektionsflaschen |
Cefalotina sodica Spanish |
SMR000058777 |
EINECS 200-394-6 |
C16H15N2NaO6S2 |
CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER |
Cephalothin sodium USAN:USP |
CEPHALOTHIN SODIUM W/ SODIUM CHLORIDE IN PLASTIC CONTAINER |
Prestwick_971 |
Keflin (TN) |
sodium;(6R,7R)-3-(acetyloxymethyl)-8-oxo-7-(2-thiophen-2-ylacetyl)amino-5-thia-1-azabicyclo4.2.0oct-2-ene-2-carboxylate |
Cephalothin sodium (USP) |
Cefalotin sodium (JP17) |
Cefalothin sodium salt,(S) |
CHEMBL1632 |
Monosodium (6R,7R)-3-(hydroxymethyl)-8-oxo-7-(2-(2-thienyl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate acetate (ester) |
SCHEMBL148785 |
SPECTRUM1500166 |
7-(2-Thienylacetamido)cephalosporanic acid sodium salt |
HMS500E19 |
DTXSID30891362 |
HMS1570O19 |
HMS1920K11 |
HMS2091A14 |
HMS2097O19 |
HMS3260J08 |
HMS3714O19 |
HY-B1275 |
Cephalothin sodium, Cefalotin sodium |
Tox21_500283 |
CCG-38923 |
s4594 |
AKOS015896088 |
CS-4850 |
KS-1135 |
LP00283 |
MCULE-2927862684 |
NSC 756667 |
NCGC00093737-01 |
NCGC00260968-01 |
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-8-oxo-7-((2-thienylacetyl)amino)-, monosodium salt, (6R,7R)- |
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-8-oxo-7-((2-thienylacetyl)amino)-, monosodium salt, (6R-trans)- |
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(hydroxymethyl)-8-oxo-7-(2-(2-thienyl)acetamido)-, acetate, monosodium salt |
AC-15529 |
Cephalothin sodium salt, 96.0-101.0% |
EU-0100283 |
C 4520 |
C-2720 |
C08100 |
D00907 |
Q27106126 |
7-(THIOPHENE-2-ACETAMIDO)CEPHALOSPORANIC ACID SODIUM |
Cephalothin sodium salt, BioReagent, suitable for cell culture |
Cephalotin sodium salt, Antibiotic for Culture Media Use Only |
Cefalotin sodium, European Pharmacopoeia (EP) Reference Standard |
Cephalothin sodium, United States Pharmacopeia (USP) Reference Standard |
sodium 7beta-(2-thienylacetamido)-3-acetoxymethyl-3-cephem-4-carboxylate |
Cefalotin for impurity B identification, European Pharmacopoeia (EP) Reference Standard |
sodium (6R, 7R)-3-acetoxymethyl-7-(thien-2-ylacetamido)ceph-3-em-4-carboxylate |
sodium (6R,7R)-3-acetoxymethyl-7-(thien-2-ylacetamido)ceph-3-em-4-carboxylate |
(6R,7R)-3-ACETOXYMETHYL-8-OXO-7-(2-THIOPHEN-2-YL-ACETYLAMINO)-5-THIA-1-AZA-BICYCLO4.2.0OCT-2-ENE-2-CARBOXYLATE SODIUM |
Monosodium (6R,7R)-3-(hydroxymethyl)-8-oxo-7-(2-(2-thienyl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate acetate |
sodium (6R,7R)-3-(acetoxymethyl)-8-oxo-7-(2-thienylacetyl)amino-5-thia-1-azabicyclo4.2.0oct-2-ene-2-carboxylate |
sodium (6R,7R)-3-(acetyloxymethyl)-8-oxo-7-(2-thiophen-2-ylacetyl)amino-5-thia-1-azabicyclo4.2.0oct-2-ene-2-carboxylate |
sodium (6R,7R)-3-(acetyloxy)methyl-8-oxo-7-2-(thiophen-2-yl)acetamido-5-thia-1-azabicyclo4.2.0oct-2-ene-2-carboxylate |
Experimental Data
CEPHALOTHIN SODIUM
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33 | umol/L | 6 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
CEPHALOTHIN SODIUM
Statistics Data
CEPHALOTHIN SODIUM
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 6 | 1 | 1 |
Statistics Data Visualization
CEPHALOTHIN SODIUM
